# Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients

Study · id `cardio:ct-nct05752929` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05752929](<https://clinicaltrials.gov/study/NCT05752929>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05752929

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

## Technical summary

Registry record NCT05752929. Randomized; no masking; primary purpose treatment. Start 2016-01-01 (actual); primary completion 2018-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 116 participants (enrolled count; ClinicalTrials.gov record NCT05752929, source copy `cardio:ctgov-nct05752929-2023-03-03`, retrieved 2026-10-26)
- Started: 2016-01-01 (actual) (ClinicalTrials.gov record NCT05752929, source copy `cardio:ctgov-nct05752929-2023-03-03`, retrieved 2026-10-26)
- Primary completion: 2018-12-31 (actual) (ClinicalTrials.gov record NCT05752929, source copy `cardio:ctgov-nct05752929-2023-03-03`, retrieved 2026-10-26)
- Completion: 2019-12-31 (actual) (ClinicalTrials.gov record NCT05752929, source copy `cardio:ctgov-nct05752929-2023-03-03`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05752929-2023-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients
- Acronym: CAPADOCIA1
- Condition: Diabete Type 2
- Condition: Hyperglycemia
- Intervention (Drug): Insulin
- Intervention (Drug): insulin
- Lead sponsor: Hospital Universitario Clinica San Rafael
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: dd424168aeb471ab74d905ba887cc346462266e495e88b2c1eaa811b92cd45d8
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
